Sodium Hydroxide → HCID 66955807, 화합물
반응식
[CH3:1][C:2]1[C:7]([CH:8]([CH2:13][CH2:14][CH3:15])[C:9]([O:11]C)=[O:10])=[C:6]([O:16][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)[N:5]=[C:4]([C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[N:3]=1.[OH-].[Na+]>CO>[CH3:1][C:2]1[C:7]([CH:8]([CH2:13][CH2:14][CH3:15])[C:9]([OH:11])=[O:10])=[C:6]([O:16][C:17]2[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=2)[N:5]=[C:4]([C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[N:3]=1참가 물질
4
실험 절차
This compound was prepared according to general method D from methyl 2-(4-methyl-6-phenoxy-2-phenylpyrimidin-5-yl)pentanoate (0.082 g; 0.218 mmol), sodium hydroxide 10N (0.218 mL; 2.18 mmol) in methanol (2 mL) to afford 0.056 g (68%) of the title compound as a white solid.